References
Central Brain Tumor Registry of the United States: 2014 CBTRUS fact sheet http://www.cbtrus.org/factsheet/factsheet.html. Accessed on October 14 2015
National Cancer Institute. Statistics for year 2015 http://seer.cancer.gov/statfacts/html/brain.html. Accessed on September 30, 2015
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
Van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375
Davis F, McCarthy BJ, Berger MS (1999) Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the United States; surveillance, epidemiology, and end results; and National Cancer Data Base. Neuro-oncology 1(3):205–211
National Cancer Registry Program (ICMR) http://www.ncrpindia.org/index.aspx. Accessed on September 30, 2015
Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neuro-oncol 87:111–114
Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130
Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270
Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557–564
Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Path 21:1455–1465
Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867–890 (vii)
Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347–3350
Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10(1):10–18
Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE (2011) No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31(3):959–960
Wick W, Platten M (2014) CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-oncology 16(3):332–333
Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V (2012) No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res 32(3):1113–1115
Lehrer S (2012) Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses 78(5):657–658
Acknowledgments
The authors thank department of pathology (Krishna Institute of Medical Sciences) for assistance with histopathological staining and patient registry, DBT for student fellowship, DST (No SB/EMEQ-257/2013) and UPE (UH/UGC/UPE-2 Interface studies/Research Projects/B1.4) for lab funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deshpande, R.P., Babu, D., Panigrahi, M. et al. Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India. J Neurooncol 129, 383–387 (2016). https://doi.org/10.1007/s11060-016-2183-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2183-0